362 related articles for article (PubMed ID: 23856032)
1. FOXM1 promotes the epithelial to mesenchymal transition by stimulating the transcription of Slug in human breast cancer.
Yang C; Chen H; Tan G; Gao W; Cheng L; Jiang X; Yu L; Tan Y
Cancer Lett; 2013 Oct; 340(1):104-12. PubMed ID: 23856032
[TBL] [Abstract][Full Text] [Related]
2. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
3. FOXA2 attenuates the epithelial to mesenchymal transition by regulating the transcription of E-cadherin and ZEB2 in human breast cancer.
Zhang Z; Yang C; Gao W; Chen T; Qian T; Hu J; Tan Y
Cancer Lett; 2015 Jun; 361(2):240-50. PubMed ID: 25779673
[TBL] [Abstract][Full Text] [Related]
4. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
[TBL] [Abstract][Full Text] [Related]
5. miR-181b-3p promotes epithelial-mesenchymal transition in breast cancer cells through Snail stabilization by directly targeting YWHAG.
Yoo JO; Kwak SY; An HJ; Bae IH; Park MJ; Han YH
Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1601-11. PubMed ID: 27102539
[TBL] [Abstract][Full Text] [Related]
6. hRAD9 functions as a tumor suppressor by inducing p21-dependent senescence and suppressing epithelial-mesenchymal transition through inhibition of Slug transcription.
Wen FC; Chang TW; Tseng YL; Lee JC; Chang MC
Carcinogenesis; 2014 Jul; 35(7):1481-90. PubMed ID: 24403312
[TBL] [Abstract][Full Text] [Related]
7. Relationship between circulating tumor cells and epithelial to mesenchymal transition in early breast cancer.
Mego M; Cierna Z; Janega P; Karaba M; Minarik G; Benca J; Sedlácková T; Sieberova G; Gronesova P; Manasova D; Pindak D; Sufliarsky J; Danihel L; Reuben JM; Mardiak J
BMC Cancer; 2015 Jul; 15():533. PubMed ID: 26194471
[TBL] [Abstract][Full Text] [Related]
8. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.
Tan X; Fu Y; Chen L; Lee W; Lai Y; Rezaei K; Tabbara S; Latham P; Teal CB; Man YG; Siegel RS; Brem RF; Fu SW
Oncotarget; 2016 Jan; 7(1):293-307. PubMed ID: 26588055
[TBL] [Abstract][Full Text] [Related]
9. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
Hsu HY; Lin TY; Hwang PA; Tseng LM; Chen RH; Tsao SM; Hsu J
Carcinogenesis; 2013 Apr; 34(4):874-84. PubMed ID: 23275155
[TBL] [Abstract][Full Text] [Related]
10. HMGA2 induces transcription factor Slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression.
Li Y; Zhao Z; Xu C; Zhou Z; Zhu Z; You T
Cancer Lett; 2014 Dec; 355(1):130-40. PubMed ID: 25218351
[TBL] [Abstract][Full Text] [Related]
11. FOXM1 promotes lung adenocarcinoma invasion and metastasis by upregulating SNAIL.
Wei P; Zhang N; Wang Y; Li D; Wang L; Sun X; Shen C; Yang Y; Zhou X; Du X
Int J Biol Sci; 2015; 11(2):186-98. PubMed ID: 25561901
[TBL] [Abstract][Full Text] [Related]
12. miR-134 inhibits epithelial to mesenchymal transition by targeting FOXM1 in non-small cell lung cancer cells.
Li J; Wang Y; Luo J; Fu Z; Ying J; Yu Y; Yu W
FEBS Lett; 2012 Oct; 586(20):3761-5. PubMed ID: 23010597
[TBL] [Abstract][Full Text] [Related]
13. FOXM1 (Forkhead box M1) in tumorigenesis: overexpression in human cancer, implication in tumorigenesis, oncogenic functions, tumor-suppressive properties, and target of anticancer therapy.
Wierstra I
Adv Cancer Res; 2013; 119():191-419. PubMed ID: 23870513
[TBL] [Abstract][Full Text] [Related]
14. Osteopontin up-regulates critical epithelial-mesenchymal transition transcription factors to induce an aggressive breast cancer phenotype.
Li NY; Weber CE; Mi Z; Wai PY; Cuevas BD; Kuo PC
J Am Coll Surg; 2013 Jul; 217(1):17-26; discussion 26. PubMed ID: 23619316
[TBL] [Abstract][Full Text] [Related]
15. Glucose-Dependent FOXM1 Promotes Epithelial-to-Mesenchymal Transition Via Cellular Metabolism and Targeting Snail in Human Pancreatic Cancer.
Kyuno T; Kohno T; Konno T; Yamaguchi H; Kyuno D; Imamura M; Kimura Y; Kojima T; Takemasa I
Pancreas; 2020 Feb; 49(2):273-280. PubMed ID: 32011531
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of FOXM1 is associated with EMT and is a predictor of poor prognosis in non-small cell lung cancer.
Kong FF; Qu ZQ; Yuan HH; Wang JY; Zhao M; Guo YH; Shi J; Gong XD; Zhu YL; Liu F; Zhang WY; Jiang B
Oncol Rep; 2014 Jun; 31(6):2660-8. PubMed ID: 24715097
[TBL] [Abstract][Full Text] [Related]
17. KLF8 promotes tumorigenesis, invasion and metastasis of colorectal cancer cells by transcriptional activation of FHL2.
Yan Q; Zhang W; Wu Y; Wu M; Zhang M; Shi X; Zhao J; Nan Q; Chen Y; Wang L; Cheng T; Li J; Bai Y; Liu S; Wang J
Oncotarget; 2015 Sep; 6(28):25402-17. PubMed ID: 26320172
[TBL] [Abstract][Full Text] [Related]
18. Increased FoxM1 expression is a target for metformin in the suppression of EMT in prostate cancer.
Wang Y; Yao B; Wang Y; Zhang M; Fu S; Gao H; Peng R; Zhang L; Tang J
Int J Mol Med; 2014 Jun; 33(6):1514-22. PubMed ID: 24676803
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-30a increases tight junction protein expression to suppress the epithelial-mesenchymal transition and metastasis by targeting Slug in breast cancer.
Chang CW; Yu JC; Hsieh YH; Yao CC; Chao JI; Chen PM; Hsieh HY; Hsiung CN; Chu HW; Shen CY; Cheng CW
Oncotarget; 2016 Mar; 7(13):16462-78. PubMed ID: 26918943
[TBL] [Abstract][Full Text] [Related]
20. Activated androgen receptor promotes bladder cancer metastasis via Slug mediated epithelial-mesenchymal transition.
Jing Y; Cui D; Guo W; Jiang J; Jiang B; Lu Y; Zhao W; Wang X; Jiang Q; Han B; Xia S
Cancer Lett; 2014 Jun; 348(1-2):135-45. PubMed ID: 24662746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]